Viewing nowBarofezil Tablets 10 mg (Donepezil Hydrochloride Monohydrate)
Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

MFDS item code 200703338 · Notified 2007.03.22 · Insurance code 648501020
Treatment of symptoms of Alzheimer's-type dementia
This medicine is used for the treatment of symptoms of Alzheimer's type dementia. It helps improve memory decline, cognitive dysfunction, and difficulties in daily life, enabling patients to lead a better life.
○ Adults: Administer 5 mg of donepezil hydrochloride once daily at bedtime. If sleep disturbances such as unusual dreams, nightmares, or insomnia occur, taking this medicine in the morning may be considered. Since donepezil concentrations reach steady state 15 days after administration and the incidence of adverse reactions may be affected by the rate of dose escalation, administer the 5 mg dose for 4~6 weeks. After assessing the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg once daily, monitor for gastrointestinal adverse reactions. If treatment is discontinued, the effect gradually decreases; no rebound effect occurs after abrupt discontinuation. ○ Women aged 85 years or older with low body weight: Adverse reactions occur more frequently, so careful monitoring is required. Elderly women with low body weight should not exceed 5 mg once daily.
○ Children: There is no experience with use in children.
This drug is used to treat symptoms of Alzheimer's type dementia with Donepezil Hydrochloride as the active ingredient. First, this medicine should not be administered to patients allergic to Donepezil Hydrochloride, piperidine derivatives, or any components of this product. Also, it is safe for pregnant women, those who may become pregnant, and breastfeeding women to avoid using this drug. Patients with heart diseases, especially those with sick sinus syndrome or cardiac conduction disorders, should use this drug cautiously as it may slow the heart rate or cause arrhythmias. Patients taking non-steroidal anti-inflammatory drugs or with a history of peptic ulcers should exercise caution as there is a risk of worsening ulcers due to increased gastric acid secretion. Patients with a history of asthma or chronic obstructive pulmonary disease may experience worsening symptoms due to bronchoconstriction and increased mucus secretion; therefore, careful administration is required. Patients with extrapyramidal disorders such as Parkinson's disease should be careful as this drug can worsen symptoms. Serious adverse reactions such as fainting, bradycardia, heart block, gastrointestinal bleeding, liver function abnormalities, seizures, movement disorders, neuroleptic malignant syndrome, rhabdomyolysis, respiratory distress, acute pancreatitis, acute renal failure, and sudden death may occur while taking this drug; if any abnormal symptoms occur, discontinue use immediately and consult a healthcare professional. Common side effects include nausea, vomiting, diarrhea, loss of appetite, dizziness, and insomnia, and most are mild and temporary. Also, this drug may affect the heart rate, so regular ECG monitoring may be needed for patients with heart diseases. As a cholinesterase inhibitor, this drug can stimulate gastric acid secretion and gastrointestinal motility, so patients with a history of peptic ulcers should carefully monitor for symptom worsening. It may affect driving or machinery operation, so caution is needed at the initiation of treatment or during dose changes. This drug is metabolized by CYP3A4 and CYP2D6 enzymes, so when taken with drugs that inhibit or induce these enzymes, efficacy may change, requiring careful monitoring. Additionally, interactions may occur when used with other cholinergic or anticholinergic medications. It is best for pregnant or breastfeeding women to avoid this drug; if it must be used, breastfeeding should be discontinued. Safety for pediatric patients has not been established, and therefore it is not administered to them. In case of overdose, symptoms such as nausea, vomiting, bradycardia, hypotension, respiratory depression, and seizures may occur, necessitating immediate treatment at a medical facility, where antidotes such as atropine may be used. This drug should be stored out of reach of children and transferring to other containers is not advisable for maintaining quality.
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly closed container that is not air-permeable, at a temperature between 1 and 30 degrees Celsius at room temperature. Storing it this way helps maintain the drug's effectiveness over time.
Yellow round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDonepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Donepezil Hydrochloride 5mg
Tablet · Prescription medication
HanDoc Co., Ltd.

Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Yuhan Corporation

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.